Considering the earnings reaction history, The Company has topped 100% percentage. $2.07 million worth of UnitedHealth Group Inc (NYSE:UNH) shares were sold by WILSON D ELLEN. The number of times the company missed analysts' estimates is 0.
South Dakota Investment Council decreased its stake in Unitedhealth Group Inc (UNH) by 8.7% based on its latest 2016Q2 regulatory filing with the SEC. (NYSE:UNH) traded up 0.20% on Monday, hitting $134.19. UnitedHealth Group Inc (NYSE:UNH) has risen 14.22% since April 25, 2016 and is uptrending.
The health care and health technology company saw shares hit $157 apiece ahead of market's open November 29, a boost of 3.2% compared to its Monday close price. The stock has a 50 day moving average price of $143.81 and a 200-day moving average price of $139.88.
UnitedHealth Group Incorporated (NYSE:UNH) stock is presently standing at about $157.59 and lots of equity research firms seem to have a target price set on the stock.
UnitedHealth Group Incorporated (NYSE:UNH) reiterated its upbeat earnings forecast for 2016.
For trailing twelve months, BMRN attains gross profit margin of 82.00% and operating margin stands at -58.60%, that are showing consistency of trends in firm's earnings. The company earned $46.30 billion during the quarter, compared to analysts' expectations of $46.09 billion. That is compared with the $1.40 in EPS it reported during the same period a year ago. UnitedHealth Group Incorporated (NYSE:UNH) is -1.55% away from its 52 week high.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Acadian Asset Mngmt Ltd Llc has 0.01% invested in the company for 10,104 shares. The indicated annual dividend is $2.50. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group's payout ratio is now 36.93%. Also, Director Gail R. Wilensky sold 5,460 shares of the business's stock in a transaction dated Thursday, November 17th. Following the completion of the transaction, the director now directly owns 28,613 shares in the company, valued at $4,148,598.87. The sell-side target prices range from $135 to $185. The most recent short interest data show 0.85% of the company's stock are short sold. The disclosure for this sale can be found here. The average analysts gave this company a mean recommendation of 1.60. The Missouri-based Smith Moore & Co has invested 0.09% in UnitedHealth Group Inc (NYSE:UNH). "(UNH) Updates FY16 Earnings Guidance" was published by Marea Informative and is owned by of Marea Informative. If you are viewing this story on another site, it was copied illegally and reposted in violation of United States and worldwide trademark & copyright laws.
Several research analysts have issued reports on the stock. The analyst with the most positive view is estimating earnings per share of $9.08, while the most bearish is estimating EPS of $8.62 for the year. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. Van Hulzen Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $104,000. Retirement Systems of Alabama boosted its stake in shares of UnitedHealth Group by 13.2% in the third quarter. The ratio increased, as 55 funds sold all UnitedHealth Group Inc shares owned while 466 reduced positions. Institutional investors own 84.92% of the company's stock.
09/22/2016 - Evercore ISI began new coverage on UnitedHealth Group Incorporated giving the company a "buy" rating. The Company's business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx.